Published in J Virol on May 23, 2007
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
A partial form of recessive STAT1 deficiency in humans. J Clin Invest (2009) 1.59
Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem (2008) 1.32
Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol (2011) 1.26
Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog (2011) 1.17
Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J Virol (2010) 1.01
Interferon-λ in HCV Infection and Therapy. Viruses (2010) 0.98
New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One (2010) 0.98
Bunyaviruses and the type I interferon system. Viruses (2009) 0.96
Autophagic clearance of Sin Nombre hantavirus glycoprotein Gn promotes virus replication in cells. J Virol (2012) 0.85
A model system for in vitro studies of bank vole borne viruses. PLoS One (2011) 0.81
Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus. Clin Infect Dis (2015) 0.77
Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis. J Virol (2014) 0.77
What Do We Know about How Hantaviruses Interact with Their Different Hosts? Viruses (2016) 0.75
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways. PLoS Pathog (2017) 0.75
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol (2002) 11.87
IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol (2002) 11.22
Hantaviruses: a global disease problem. Emerg Infect Dis (1997) 9.67
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Type I interferons in host defense. Immunity (2006) 7.32
Hantavirus infections in Europe. Lancet Infect Dis (2003) 5.27
The interferon response circuit: induction and suppression by pathogenic viruses. Virology (2006) 4.56
Exotic emerging viral diseases: progress and challenges. Nat Med (2004) 4.54
Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol (2006) 4.21
The role of nitric oxide in innate immunity. Immunol Rev (2000) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis (1985) 2.02
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood (2006) 1.83
IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res (2006) 1.77
Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol (1996) 1.76
Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A (2002) 1.74
Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med (1976) 1.69
The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol (2006) 1.66
Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol (2004) 1.63
Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.54
IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol (2006) 1.54
Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med (2002) 1.34
Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol (2007) 1.32
Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol (2005) 1.20
Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J Virol (2003) 1.17
Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology (1996) 1.16
Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol (2004) 1.16
Thymic aplasia with lymphopenia, plasma cells, and normal immunoglobulins. Relation to measles virus infection. JAMA (1967) 1.14
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis (2006) 1.14
Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol (2006) 1.09
Hantavirus immunology. Viral Immunol (2002) 1.06
Endogenous interferon in Argentine hemorrhagic fever. J Infect Dis (1984) 1.05
Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect (2004) 1.01
Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. Virus Genes (2003) 1.00
Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res (1987) 0.97
Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol (2006) 0.93
Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J Virol (2006) 0.92
Inducible nitric oxide synthase expression inhibition by adenovirus E1A. Proc Natl Acad Sci U S A (2003) 0.89
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J Virol (2002) 0.88
Profound and prolonged lymphocytopenia with West Nile encephalitis. Clin Infect Dis (2000) 0.81
Hantavirus infections in Europe. Lancet Infect Dis (2003) 5.27
Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89
Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis (2007) 2.76
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis (2008) 1.95
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol (2006) 1.86
Influenza virus in a natural host, the mallard: experimental infection data. PLoS One (2010) 1.75
Demographic factors associated with hantavirus infection in bank voles (Clethrionomys glareolus). Emerg Infect Dis (2002) 1.56
Human hantavirus infections, Sweden. Emerg Infect Dis (2003) 1.54
Development and evaluation of a broad reacting SYBR-green based quantitative real-time PCR for the detection of different hantaviruses. J Clin Virol (2013) 1.48
Dengue viruses - an overview. Infect Ecol Epidemiol (2013) 1.40
Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J (2008) 1.39
Outbreak of Puumala virus infection, Sweden. Emerg Infect Dis (2008) 1.38
Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis (2011) 1.38
Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J Gen Virol (2010) 1.35
Migrating birds and tickborne encephalitis virus. Emerg Infect Dis (2007) 1.33
Predicting high risk for human hantavirus infections, Sweden. Emerg Infect Dis (2009) 1.30
Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol (2007) 1.29
The 2007 Rift Valley fever outbreak in Sudan. PLoS Negl Trop Dis (2011) 1.26
Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus). Emerg Infect Dis (2008) 1.22
Genetic analysis of Crimean-congo hemorrhagic fever virus in Iran. J Med Virol (2004) 1.21
Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis (2002) 1.20
Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis (2006) 1.19
Dissemination of spotted fever rickettsia agents in Europe by migrating birds. PLoS One (2010) 1.19
Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol (2004) 1.17
HIV/AIDS awareness and risk behavior among students in Semey, Kazakhstan: a cross-sectional survey. BMC Int Health Hum Rights (2008) 1.15
Habitat factors associated with bank voles (Clethrionomys glareolus) and concomitant hantavirus in northern Sweden. Vector Borne Zoonotic Dis (2005) 1.14
Fear of deportation may limit legal immigrants' access to HIV/AIDS-related care: a survey of Swedish language school students in Northern Sweden. J Immigr Minor Health (2012) 1.14
Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors (2012) 1.14
Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis (2010) 1.14
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. Virology (2009) 1.13
Optimized diagnosis of acute dengue fever in Swedish travelers by a combination of reverse transcription-PCR and immunoglobulin M detection. J Clin Microbiol (2005) 1.12
An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses. J Virol (2010) 1.12
Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J Med Virol (2004) 1.09
Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol (2003) 1.09
Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol (2006) 1.09
Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol (2011) 1.09
Migratory birds, ticks, and crimean-congo hemorrhagic fever virus. Emerg Infect Dis (2012) 1.08
Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol (2008) 1.07
Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol (2003) 1.05
Adaptation of Puumala hantavirus to cell culture is associated with point mutations in the coding region of the L segment and in the noncoding regions of the S segment. J Virol (2003) 1.04
Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther (2009) 1.04
Hantaviruses in Estonia. J Med Virol (2002) 1.04
Hantavirus antibody occurrence in bank voles (Clethrionomys glareolus) during a vole population cycle. J Wildl Dis (2003) 1.03
Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J Virol (2010) 1.01
Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis (2004) 1.00
Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine (2002) 0.98
Characterization of tick-borne encephalitis virus from Estonia. J Med Virol (2004) 0.98
Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs. Virol J (2009) 0.98
Tickborne encephalitis virus, Norway and Denmark. Emerg Infect Dis (2006) 0.98
Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice. Microbes Infect (2006) 0.97
Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg Infect Dis (2008) 0.97
[Nephropathia epidemica: high risk in Norrland during winter]. Lakartidningen (2007) 0.97
Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One (2011) 0.96
Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards. PLoS One (2011) 0.96
High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol (2004) 0.96
Pathology of Puumala hantavirus infection in macaques. PLoS One (2008) 0.95
"It is a challenge to do it the right way": an interpretive description of caregivers' experiences in caring for migrant patients in Northern Sweden. BMC Health Serv Res (2012) 0.95
HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol (2005) 0.94
Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol (2006) 0.94
Identification of Seoul hantavirus in Rattus norvegicus in Indonesia. Scand J Infect Dis (2004) 0.94
Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol (2006) 0.93
A real-time PCR assay for the monitoring of influenza A virus in wild birds. J Virol Methods (2007) 0.93
Screening migrants for tuberculosis - a missed opportunity for improving knowledge and attitudes in high-risk groups: A cross-sectional study of Swedish-language students in Umeå, Sweden. BMC Public Health (2010) 0.93
Serological assays for the detection of human andes hantavirus infections based on its yeast-expressed nucleocapsid protein. Intervirology (2006) 0.93
Complete gene sequence of a human Puumala hantavirus isolate, Puumala Umeå/hu: sequence comparison and characterisation of encoded gene products. Virus Res (2004) 0.93
Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol (2005) 0.92
Genetic analysis of Thailand hantavirus in Bandicota indica trapped in Thailand. Virol J (2006) 0.92
DNA microarray technique for detection and identification of seven flaviviruses pathogenic for man. J Med Virol (2005) 0.91
Milder winters in northern Scandinavia may contribute to larger outbreaks of haemorrhagic fever virus. Glob Health Action (2009) 0.91
Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog (2013) 0.91
Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine (2010) 0.91
Saaremaa hantavirus in Denmark. J Clin Virol (2004) 0.91
Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods (2003) 0.90
Microarray technology for identification and distinction of hantaviruses. J Med Virol (2004) 0.90
Genetic interaction between Dobrava and Saaremaa hantaviruses: now or millions of years ago? J Virol (2003) 0.89
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology (2004) 0.89
Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge. Antivir Ther (2008) 0.88
Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins. Vaccine (2006) 0.87
Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol (2002) 0.87
Quality control measures for the serological diagnosis of hantavirus infections. J Clin Virol (2003) 0.87
Puumala hantavirus and Myodes glareolus in northern Europe: no evidence of co-divergence between genetic lineages of virus and host. J Gen Virol (2010) 0.87
Rate of evolution and molecular epidemiology of tick-borne encephalitis virus in Europe, including two isolations from the same focus 44 years apart. J Gen Virol (2011) 0.87
Identification of Swedish mosquitoes based on molecular barcoding of the COI gene and SNP analysis. Mol Ecol Resour (2013) 0.87
Modelling zoonotic diseases in humans: comparison of methods for hantavirus in Sweden. Int J Health Geogr (2012) 0.86